Dr. Abraham Kanate, MD – Scottsdale, AZ
Matthew Shields Overview of Dr. Kanate
Dr. Abraham Kanate is an oncologist in Scottsdale, AZ and is affiliated with multiple hospitals in the area, including HonorHealth Scottsdale Shea Medical Center and West Virginia University Hospitals. He received his medical degree from St. John's Medical College and has been in practice 14 years. He is one of 38 doctors at West Virginia University Hospitals and one of 54 doctors at HonorHealth Scottsdale Shea Medical Center who specialize in Oncology. He has more than 60 publications and over 500 citings.
Education & Training
West Virginia UniversityFellowship, Hematology and Medical Oncology, 2008 - 2011
West Virginia UniversityResidency, Internal Medicine, 2005 - 2008
St. John's Medical CollegeClass of 2003
Certifications & Licensure
CA State Medical License 2011 - Present
AZ State Medical License 2021 - 2025
WV State Medical License 2008 - 2022
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
Clinical Trials
Publications & Presentations
PubMed
- 10 citations
Updated Indications for Immune Effector Cell Therapy: 2023 Guidelines from the American Society for Transplantation and Cellular Therapy.
Abraham S Kanate, Navneet Majhail, Zachariah DeFilipp, Binod Dhakal, Bhagirathbhai Dholaria, Betty Hamilton, Alex F Herrera, Yoshihiro Inamoto, Tania Jain, Miguel-Ange...> ;Transplantation and Cellular Therapy. 2023 Oct 1 - 4 citations
Haploidentical Versus Matched Unrelated Donor Transplants Using Post-Transplantation Cyclophosphamide for Lymphomas.
Alberto Mussetti, Abraham S Kanate, Tao Wang, Meilun He, Mehdi Hamadani, Hervé Finel Sr, Ariane Boumendil Sr, Bertram Glass, Luca Castagna, Alida Dominietto, Joseph Mc...> ;Transplantation and Cellular Therapy. 2023 Mar 1 - 3 citations
Pembrolizumab for patients with non-Hodgkin lymphoma: phase 1b KEYNOTE-013 study.
John Kuruvilla, Philippe Armand, Mehdi Hamadani, Justin Kline, Craig H Moskowitz, David Avigan, Joshua D Brody, Vincent Ribrag, Alex F Herrera, Franck Morschhauser, Ab...> ;Leukemia & Lymphoma. 2023 Jan 1 - Join now to see all
Lectures
Health-Related Quality of Life Among Patients with Relapsed or Refractory Multiple Myeloma Who Received Pomalidomide, Bortezomib, and Low-Dose Dexamethasone Versus Bor...
2018 ASH Annual Meeting - San Diego, CA - 12/1/2018